Tagged with

Genzyme Genzyme Turkey’s general manager discusses diagnosis and treatment access issues for rare diseases, the need for prioritization of patient welfare in all aspects of health policy, and the importance of the Turkish market and its potential to Genzyme globally. For rare diseases, do Turkish patients have adequate access to the…

UCB UCB’s managing director for Turkey and the MEA region discusses UCB’s leading patient centricity, how UCB is addressing gaps in the Turkish healthcare system surrounding epileptic patients, and the company’s plan for regional expansion through partnerships. Given your patient centricity and UCB’s unique perspective, how would you assess the sectors approach…

licensing The president of Laprophan, a leading Moroccan pharma company, discusses the company’s commitment to R&D, and how it has found success through innovation and partnership with leading MNCs. Established in 1949, Laprophan was one of the pioneering companies of Morocco’s pharmaceutical industry, and is now among the leading national laboratories.…

generics The president of both Polymédic, a local producer, and AMMG, the Moroccan generics association, discusses the role of generics in the Moroccan market today, and what steps the country must take in order to realize its pharma potential. Morocco pioneered the pharmaceutical industry in Africa; yet, today investors are fewer…

distribution The CEO of ZenithPharma discusses the potential of Africa for Moroccan pharma companies, and what it takes to succeed in the Moroccan pharma market. ZenithPharma’s headquarters are located in Agadir. Why did you choose Agadir? Historically, we started our business in the pharmaceutical industry here when we opened a wholesale…

association The CEO of Morocco’s oldest pharma association discusses the latest regulatory changes in Morocco and their impact on its members, as well as the position of Moroccan pharma in the African and European context. You have significant experience in the pharmaceutical industry in Morocco. What have been the key steps…

access The general manager of Iberma discusses the history of the Moroccan pharmaceutical industry, new measures to improve access, and working on Moroccan-European partnerships in the pharma sector. You have a long experience of the Moroccan pharmaceutical industry. What have been the most significant changes throughout its history? Morocco initiated its…

manufacturing The corporate development director and business development manager of UpPharma explain why Market Expansion Services (MES) model represents a unique business opportunity for firms looking to establish themselves in the Mexican pharmaceutical market, why small and medium sized companies are now considering investing in the country and how the vision…

Servier The general manager of Servier Morocco reviews the situation of the market following the recent price cuts, how the local environment is changing with the rise of generics, and reveals his vision of creating a regional hub for Servier in Morocco. Today, Servier is number one in the Moroccan market for…

social security Seguro Integral de Salud (SIS) is the social protection scheme run under Peru’s Ministry of Health designed to provide health services to the country’s unemployed and poverty-stricken citizens. Its leader, Pedro Grillo, discusses how new reform is helping to provide better treatments, particularly for oncology, and ultimately universal coverage by…

Eurofarma Eurofarma entered the Peruvian market in 2013 through the acquisition of local player Refasa-Carrión. Rómulo García, the affiliate’s ambitious general manager, discusses the merge and his quest to become a top ten player in the market. Can you give us a brief introduction to Eurofarma; starting from your foundation to…

MOH Cesar Amaro, director general of Digemid, highlights the evolution of Peru’s recently-established regulatory agency while taking into account the challenges surrounding the institution on a daily basis, like approval times, counterfeit drugs, and adapting to modernity. What are the main priorities of Digemid today? I have been running Digemid since 2014. Our…